Tranquility Partners, LLC Gilead Sciences, Inc. Transaction History

Tranquility Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $184,938 - $231,747	-3,193 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $1,557 - $1,767	24 Added 0.76%	3,193 $232,000
Q3 2021 Oct 20, 2021	BUY	$67.69 - $73.03 $214,509 - $231,432	3,169 New	3,169 $221,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $163,012 - $204,960	-2,625 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $189,892 - $220,500	2,625 New	2,625 $202,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tranquility Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Tranquility Partners, LLC with notifications on news.